2024 APAGE-ISMIVS HIFU Series Webinars – Episode 1
The first episode of the 2024 APAGE-ISMIVS HIFU Series Webinars kicked off on May 9th. Chaired by Prof. Chi-Chang Chang, the Superintendent of E-Da Da Chang Hospital, and Dr. Selva, Consultant Obstetrician and Gynecologist of Mahkota Medical Center, the session discussed the prevention and treatment of cervical cancer.
Prof. Chyi-Long Lee, the Chairman of the Board of Trustees of APAGE and the Professor of Chang Gung Memorial Hospital, discussed the advancements in cancer surgery, emphasizing the benefits of minimally invasive techniques such as laparoscopic and robotic surgery. He highlighted the importance of standardization, surgeon proficiency, and the use of appropriate instrumentation for successful outcomes. He also affirmed the trend towards minimally invasive surgery in their department, particularly for early cancer cases.
Prof. Qiuling Shi, the Deputy Director of the State Key Laboratory of Ultrasound in Medicine and Engineering, presented a brief overview of their community-based projects aimed at cervical cancer elimination, according to the WHO's 2030 goals. The discussion focused on the potential impact of treatment strategies on cervical cancer mortality rates. Then she discussed the importance of screening and treatment for women with HPV infection and shared that in China, despite high screening rates for breast and cervical cancer, the follow-up rate after a positive HPV test was limited. To address this, a cohort study was initiated in a low-income county in China with the aim of improving follow-up rates and identifying factors that influence treatment decisions.
Dr Xi Wang, the Head of the Medical Research Department of the National Engineering Research Center of Ultrasound Medicine of China, introduced the use of focused ultrasound for the treatment of cervical diseases, emphasizing its unique features such as short focal depth, no ionizing radiation, and minimal impact on surrounding tissue. She highlighted the effectiveness of this treatment in destroying diseased tissue while preserving healthy tissue, with low recurrence rates and improved peripheral nerve function. The treatment process, outcomes, and safety were also discussed.